A4 Study - Anti-Amyloid Treatment in Asymptomatic Alzheimer#s Disease: ADC-040-A4 (Lilly # H8A-MC-LZAZ)

  • Jicha, Gregory (PI)
  • Caban-Holt, Allison (CoI)
  • Murphy, Richard (CoI)
  • Smith, Charles (CoI)

Grants and Contracts Details


The A4 study is designed to test the hypothesis that solanezumab, will slow decline on a cognitive composite measure designed to be sensitive to early decline in the preclinical stages of AD.
Effective start/end date12/31/122/29/16


  • University of California San Diego Health: $640,800.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.